Clinical Trials Logo

Spinal Cord Compression clinical trials

View clinical trials related to Spinal Cord Compression.

Filter by:
  • Terminated  
  • Page 1

NCT ID: NCT03655080 Terminated - Cord Compression Clinical Trials

Pulsed Abraxane and Radiotherapy for Improving and Maintaining Ambulation After Cancer-Related Cord Compression

Start date: January 9, 2019
Phase: Phase 2
Study type: Interventional

The purpose of this research study is to look at a combination treatment of radiation therapy and a drug called Abraxane to treat epidural spinal cord compression.

NCT ID: NCT03451474 Terminated - Clinical trials for Spinal Cord Injuries

Restoring Hand Function Utilizing Nerve Transfers in Persons With Cervical Spinal Cord Injuries

Start date: April 1, 2018
Phase: N/A
Study type: Interventional

The primary objective of this study is to evaluate the safety and efficacy of nerve transfer surgery for restoring hand function as a therapy for patients with cervical spinal cord injury.

NCT ID: NCT02167633 Terminated - Neoplasm Metastasis Clinical Trials

Stereotactic Radiosurgery in Metastatic Spinal Cord Compression

Stereocord
Start date: July 2014
Phase: N/A
Study type: Interventional

To determine whether stereotactic radiosurgery of metastatic spinal cord compression is equivalent to decompressive surgery followed by external body radiation therapy to maintain ability to walk at 6 weeks.

NCT ID: NCT01407341 Terminated - Clinical trials for Spinal Cord Compression

Beta-Tricalcium Phosphate Bone Graft in Treating Patients Undergoing Surgery For Metastatic Spine Cancer

Start date: June 2011
Phase: Phase 1
Study type: Interventional

This pilot clinical trial studies beta-tricalcium phosphate bone graft in treating patients undergoing surgery for metastatic spine cancer. A bone graft may help healing and bone growth in patients undergoing surgery for spine cancer

NCT ID: NCT00786968 Terminated - Clinical trials for Mucopolysaccharidosis I

Extension Study of Intrathecal Enzyme Replacement Therapy for MPS I

Start date: January 2008
Phase: Phase 1
Study type: Interventional

This is a one-year extension study of the use of laronidase into the spinal fluid to treat spinal cord compression in mucopolysaccharidosis I. Mucopolysaccharidosis I is a rare genetic condition due to deficiency of the enzyme alpha-l-iduronidase. Spinal cord compression occurs in this condition due to accumulation of material called glycosaminoglycans (GAG). Laronidase is the manufactured form of the enzyme alpha-l-iduronidase that is deficient in mucopolysaccharidosis I patients. The aim of this study is to determine whether laronidase is safe and effective when given into the spinal fluid as a potential non-surgical treatment for spinal cord compression due to mucopolysaccharidosis I disease. Funding Source -- FDA OOPD

NCT ID: NCT00220675 Terminated - Clinical trials for Nerve Compression Syndromes

Erythropoietin Spinal Cord Compression Randomized Trial

Start date: August 2005
Phase: Phase 2/Phase 3
Study type: Interventional

To determine whether erythropoietin, steroids and radiotherapy is safe and feasible to administer to patients with malignant spinal cord compression.

NCT ID: NCT00215527 Terminated - Clinical trials for Mucopolysaccharidosis I

Intrathecal Enzyme Replacement Therapy for Spinal Cord Compression in Mucopolysaccharidosis (MPS) I

Start date: November 2005
Phase: Phase 1
Study type: Interventional

The investigators are studying the use of enzyme replacement therapy into the spinal fluid for treatment of spinal cord compression in the Hurler-Scheie and Scheie forms of mucopolysaccharidosis I (MPS I). Funding source -- FDA OOPD